local_hospital

Centre Hospitalier Regional Universitaire De Tours

Address
lock Available on a paid plan

Neoplasms Research

At Centre Hospitalier Regional Universitaire De Tours, cancer research focuses on non-small cell lung cancer, especially previously untreated locally advanced disease. The trials in this area are designed to help determine whether new treatment approaches can better control the cancer and improve patient outcomes.

  • Studying stage 3 NSCLC that cannot be removed surgically
  • Evaluating treatment effectiveness by comparing disease control over time
  • Exploring new therapy options for hard-to-treat lung cancer

This research reflects a strong interest in advancing care for patients with complex thoracic cancers through better treatment strategies.

Psychiatry and Psychology Research

The site also conducts clinical studies in mental disorders, with a focus on depressive symptoms in nursing-home residents living with neurocognitive disorders. These trials aim to assess whether add-on treatments can improve mood and support better symptom management in a vulnerable older population.

  • Addressing depression in residents with neurocognitive impairment
  • Comparing symptom changes between an active supportive treatment and placebo
  • Testing ways to improve response when standard antidepressants are not enough

This area highlights interest in practical approaches to psychiatric care and improving quality of life for patients with overlapping cognitive and emotional challenges.

Site Overview

assignment
2
connected trials
corporate_fare
2
sponsors
science
12
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
2
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
2
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 978 other sites in France

description
Trial volume
2
Outperforms 44% of sites
public
Therapeutic diversity
2areas
Outperforms 40% of sites
groups
Sponsor diversity
2sponsors
Outperforms 45% of sites

Therapeutic Area Benchmark — France

Select a therapeutic area to compare against other sites in France.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: France

Market Share

Country: France

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Centre Hospitalier Regional Universitaire De Tours

lock Showing 1 of 2 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
Evaluation of Nitrous Oxide and Oxygen as Adjunctive Therapy to Antidepressants in Treating Depressive Symptoms in Neurocognitive Disorder PatientsCentre Hospitalier Regional Universitaire De ToursPhase IIRecruitingMay 2026

IMP list

lock Showing 1 of 12 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Carboplatin1Unknown2019-11-202019-11-20

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.